Review
Open access
Aug 2026
Tumor response to neoadjuvant treatment as a predictor of benefit for adjuvant treatment in esophago-gastric cancers: a systematic review and meta-analysis
Pathological response to neoadjuvant chemotherapy may help stratify oncological benefit from subsequent adjuvant chemotherapy, potentially supporting more personalized adjuvant treatment decisions in esophago-gastric cancer.
S. M. Jinnaah, L. Owens, C. Cabalag et al.
· ESMO gastrointestinal oncolo... · 0 citations